ID

16624

Descripción

Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc ( OSI Pharmaceuticals ) A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of single-agent Tarceva® (erlotinib) following complete tumor resection with or without adjuvant chemotherapy in patients with stage IB-IIIA non-small cell lung carcinoma who have EGFR-positive tumors. See https://clinicaltrials.gov/ct2/show/NCT00373425 Study Drug Administration

Link

https://clinicaltrials.gov/ct2/show/NCT00373425

Palabras clave

Versiones (2)
  1. 27/7/16 27/7/16 -
  2. 1/8/16 1/8/16 -
Subido en

27 de julio de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Test A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors (RADIANT) NCT00373425

Inglés

Study Drug Administration A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors (RADIANT) NCT00373425

1 formularios  
Header
Descripción

Header

Site Number
Descripción

Site number

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0018704
UMLS CUI [1,2]
C0600091
Patient Number
Descripción

patient number

Tipo de datos

integer

Alias
UMLS CUI [1]
C1830427
Study Drug Administration
Descripción

Study Drug Administration

Start Date
Descripción

Study Drug Administration Start Date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0808070
Administered Dose
Descripción

Dose

Tipo de datos

float

Unidades de medida
  • mg
Alias
UMLS CUI [1]
C0178602
mg
Stop Date
Descripción

Study Drug Administration Stop Date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0806020
Dose Modification (Record toxicities on the Adverse Events page.)
Descripción

Study Drug Dose Modification

Tipo de datos

integer

Alias
UMLS CUI [1]
C1707811
If other, specify:
Descripción

Study Drug Dose Modification

Tipo de datos

text

Alias
UMLS CUI [1]
C1707811
Missed Doses (Record the number of missed doses, if any, for the time between the start and stop dates.)
Descripción

Missed Doses

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1709043
UMLS CUI [1,2]
C0750480
Volver a la parte superior de la página

Similar models

Study Drug Administration A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors (RADIANT) NCT00373425

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Header
Site number
Item
Site Number
integer
C0018704 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
patient number
Item
Patient Number
integer
C1830427 (UMLS CUI [1])
Item Group
Study Drug Administration
Study Drug Administration Start Date
Item
Start Date
date
C0013227 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
Dose
Item
Administered Dose
float
C0178602 (UMLS CUI [1])
Study Drug Administration Stop Date
Item
Stop Date
date
C0013227 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item
Dose Modification (Record toxicities on the Adverse Events page.)
integer
C1707811 (UMLS CUI [1])
Study Drug Dose Modification
Code List
Dose Modification (Record toxicities on the Adverse Events page.)
CL Item
Drug-related Toxicity (AE) (1)
CL Item
Nondrug-related Toxicity (AE) (2)
CL Item
Patient Request  (3)
CL Item
Toxicity lmproved  (4)
CL Item
No Modification (5)
CL Item
Other (specify) (6)
Study Drug Dose Modification
Item
If other, specify:
text
C1707811 (UMLS CUI [1])
Missed Doses
Item
Missed Doses (Record the number of missed doses, if any, for the time between the start and stop dates.)
integer
C1709043 (UMLS CUI [1,1])
C0750480 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial